Skip to main content
. 2013 Dec 13;2013(12):CD003388. doi: 10.1002/14651858.CD003388.pub4

Asukai 2010.

Methods Randomised controlled trial
Participants 24 individuals (Japanese) with DSM‐IV PTSD after various traumas (21 women, 3 men)
Interventions 8 ‐ 15 90‐minute sessions of Prolonged Exposre (TFCBT) (n = 12) sessions vs treatment as usual (TAU) (n = 12)
Outcomes CAPS, IES‐R, CES‐D, GHQ‐28
Notes Therapists were masters level psychologists. TAU included pharmacotherapy. Baseline demographics were similar within both groups. The difference in scores between both groups was nonsignificant at baseline on any of the assessment scales. Treatment adherence was measured.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk Quote: "randomized by the study site based on computer‐generated random digit numbers by permuted blocks between 4 and 8."
Allocation concealment (selection bias) Unclear risk Comment: Allocation concealment was not reported. Participants were randomised at the study site.
Incomplete outcome data (attrition bias) 
 All outcomes Low risk Quote: "intention‐to‐treat analysis was performed to determine the relative effect between the two treatment groups for each periodic posttreatment assessment, and those between pre‐PE (after the waiting period) and post‐PE treatment in the control group (CAPS total score, IES‐R, CES‐D, and GHQ‐28)."
Comment: 3 dropped out from TFCBT, and one from TAU. A reason was only reported for one of these drop‐outs.
Selective reporting (reporting bias) Low risk Comment: All specified and expected outcomes appear to have been reported.
Other bias Low risk Comment: There were no other obvious sources of bias.
Blinding of participants and personnel (performance bias) 
 All outcomes High risk Comment: Participants were aware of their allocation.
Blinding of outcome assessment (detection bias) 
 All outcomes Low risk Quote: "Two independent female masters‐level psychologists, who were unaware of the patients’ treatment group, performed all assessments at pretreatment, posttreatment, and 3‐ and 6‐month follow‐up. The 12‐month follow‐up assessment was conducted via mail. Blindness was maintained by ensuring that the assessors had no access to group allocation and never talked with patients about which group they were in."